• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌合并肝窦阻塞综合征的根治性全胃切除术:1例病例报告

Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report.

作者信息

Gao Bin, Zhang Jingjing, Zhu Lei, Zhang Yaming

机构信息

Department of General Surgery, Anqing Municipal Hospital, Anqing, China.

出版信息

Front Med (Lausanne). 2025 May 9;12:1544400. doi: 10.3389/fmed.2025.1544400. eCollection 2025.

DOI:10.3389/fmed.2025.1544400
PMID:40417670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12098442/
Abstract

Hepatic sinusoidal obstruction syndrome (HSOS) is often caused by the ingestion of pyrrolizidine alkaloids (PAs). To date, research on PAs-induced HSOS remains limited. Due to differing etiologies of HSOS in Western and Eastern populations, the clinical features, imaging findings, treatment approaches, and outcomes of HSOS caused by hematopoietic stem cell transplantation or oxaliplatin may not be directly applicable to PAs-induced HSOS. PAs-induced HSOS commonly presents with painful hepatomegaly, ascites, and jaundice. Laboratory tests commonly show abnormal liver function in patients with PA-induced HSOS. Contrast-enhanced computed tomography and magnetic resonance imaging often reveal distinctive imaging features and significant histopathological liver changes in PAs-induced HSOS. These findings highlight the effectiveness of radiological imaging and liver biopsy as diagnostic tools. Treatment strategies for PAs-induced HSOS include fluid management, anticoagulation therapy, glucocorticoids, transjugular intrahepatic portosystemic shunt (TIPS), and liver transplantation. However, managing PAs-induced HSOS remains challenging. This paper presents the case of an elderly male diagnosed with gastric cancer complicated by hepatic sinusoidal obstruction syndrome. The diagnosis was based on characteristic imaging findings, a history of pyrrolizidine alkaloids ingestion, and standard diagnostic criteria, including liver biopsy and histological examination. The patient recovered fully after timely diagnosis and treatment, which included radical total gastrectomy, hepatoprotective diuretics, albumin supplementation, and low-molecular-weight heparin therapy.

摘要

肝窦阻塞综合征(HSOS)常由摄入吡咯里西啶生物碱(PAs)引起。迄今为止,关于PAs诱导HSOS的研究仍然有限。由于西方和东方人群中HSOS的病因不同,造血干细胞移植或奥沙利铂所致HSOS的临床特征、影像学表现、治疗方法及预后可能不适用于PAs诱导的HSOS。PAs诱导的HSOS通常表现为肝肿大伴疼痛、腹水和黄疸。实验室检查通常显示PAs诱导的HSOS患者肝功能异常。对比增强计算机断层扫描和磁共振成像常显示PAs诱导的HSOS具有独特的影像学特征和明显的肝脏组织病理学变化。这些发现突出了放射影像学和肝活检作为诊断工具的有效性。PAs诱导的HSOS的治疗策略包括液体管理、抗凝治疗、糖皮质激素、经颈静脉肝内门体分流术(TIPS)和肝移植。然而,管理PAs诱导的HSOS仍然具有挑战性。本文介绍了一例老年男性患者,诊断为胃癌合并肝窦阻塞综合征。诊断基于特征性影像学表现、吡咯里西啶生物碱摄入史以及包括肝活检和组织学检查在内的标准诊断标准。患者经及时诊断和治疗后完全康复,治疗包括根治性全胃切除术、保肝利尿剂、补充白蛋白和低分子量肝素治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa9/12098442/cc609c6410fd/fmed-12-1544400-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa9/12098442/8ba54261f6d1/fmed-12-1544400-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa9/12098442/043f3e8fd839/fmed-12-1544400-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa9/12098442/4a4bc30d30b9/fmed-12-1544400-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa9/12098442/cc609c6410fd/fmed-12-1544400-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa9/12098442/8ba54261f6d1/fmed-12-1544400-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa9/12098442/043f3e8fd839/fmed-12-1544400-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa9/12098442/4a4bc30d30b9/fmed-12-1544400-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa9/12098442/cc609c6410fd/fmed-12-1544400-g004.jpg

相似文献

1
Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report.胃癌合并肝窦阻塞综合征的根治性全胃切除术:1例病例报告
Front Med (Lausanne). 2025 May 9;12:1544400. doi: 10.3389/fmed.2025.1544400. eCollection 2025.
2
Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.吡咯里西啶生物碱诱导的肝窦阻塞综合征:发病机制、临床表现、诊断、治疗和结局。
World J Gastroenterol. 2019 Jul 28;25(28):3753-3763. doi: 10.3748/wjg.v25.i28.3753.
3
Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.吡咯里西啶生物碱诱导的肝窦阻塞综合征的临床特征、CT表现及病理结果:一项回顾性研究
BMC Gastroenterol. 2020 Feb 4;20(1):30. doi: 10.1186/s12876-020-1180-0.
4
Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.吡咯里西啶生物碱诱导的肝窦阻塞综合征临床管理专家共识。
J Gastroenterol Hepatol. 2019 Apr;34(4):634-642. doi: 10.1111/jgh.14612. Epub 2019 Feb 21.
5
Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.吡咯里西啶生物碱诱导的肝窦阻塞综合征的 CT 增强扫描诊断性能。
Sci Rep. 2016 Nov 29;6:37998. doi: 10.1038/srep37998.
6
Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome.南京诊断吡咯里西啶生物碱所致肝窦阻塞综合征标准的验证
J Clin Transl Hepatol. 2021 Jun 28;9(3):345-352. doi: 10.14218/JCTH.2020.00124. Epub 2021 Mar 31.
7
Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome.经颈静脉肝内门体分流术治疗吡咯里西啶生物碱相关肝窦阻塞综合征。
World J Gastroenterol. 2020 Jun 28;26(24):3472-3483. doi: 10.3748/wjg.v26.i24.3472.
8
Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi - Case report and literature review.土三七致肝窦阻塞综合征的临床病理特征及诊断——病例报告并文献复习
Open Med (Wars). 2023 Jun 12;18(1):20230737. doi: 10.1515/med-2023-0737. eCollection 2023.
9
Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports.低分子量肝素治疗吡咯里西啶生物碱所致肝窦阻塞综合征:5例报告
J Int Med Res. 2020 Sep;48(9):300060520961916. doi: 10.1177/0300060520961916.
10
[Study of PA-HSOS severity grading to predict the prognosis of patients with PA-HSOS treated by transjugular intrahepatic portosystemic shunt].经颈静脉肝内门体分流术治疗肝小静脉闭塞病严重程度分级对患者预后的预测研究
Zhonghua Gan Zang Bing Za Zhi. 2021 Jan 20;29(1):46-53. doi: 10.3760/cma.j.cn501113-20201213-00651.

本文引用的文献

1
Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives.药物性肝窦阻塞综合征:当前进展与未来展望
Arch Toxicol. 2025 Mar;99(3):835-850. doi: 10.1007/s00204-024-03950-9. Epub 2024 Dec 24.
2
Hepatic Sinusoidal Disorders.肝窦状隙障碍。
Radiographics. 2024 Sep;44(9):e240006. doi: 10.1148/rg.240006.
3
Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment.
对异基因干细胞移植后静脉闭塞性疾病/窦性阻塞综合征(VOD/SOS)进行系统筛查和重点评估,有助于早期诊断并及时开始使用去纤苷治疗。
Front Transplant. 2022 Nov 8;1:996003. doi: 10.3389/frtra.2022.996003. eCollection 2022.
4
Analysis of laboratory parameters before the occurrence of hepatic sinusoidal obstruction syndrome in children, adolescents, and young adults after hematopoietic stem cell transplantation.造血干细胞移植后儿童、青少年和青年成人发生肝窦阻塞综合征前的实验室参数分析。
J Cancer Res Clin Oncol. 2024 Jan 11;150(1):9. doi: 10.1007/s00432-023-05561-w.
5
Histological evaluation of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: Correlation with Drum Tower Severity Scoring.吡咯里西啶生物碱诱导的肝窦阻塞综合征的组织学评价:与鼓楼严重程度评分的相关性。
Dig Liver Dis. 2024 Jul;56(7):1220-1228. doi: 10.1016/j.dld.2023.12.008. Epub 2023 Dec 26.
6
Genotyping and antibiotic susceptibility of Campylobacter species isolated from raw milk samples in Qazvin, Iran.伊朗卡兹温市生奶样本中分离的弯曲杆菌属种的基因分型和抗生素药敏性。
BMC Res Notes. 2023 Nov 6;16(1):314. doi: 10.1186/s13104-023-06576-9.
7
Prognostic risk factors for patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids.吡咯里西啶生物碱所致肝窦阻塞综合征患者的预后危险因素。
Medicine (Baltimore). 2023 Aug 11;102(32):e34698. doi: 10.1097/MD.0000000000034698.
8
Assessment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome using different scanning approaches for the ultrasonographic evaluation of portal vein blood flow and hepatic artery resistive index in hematopoietic stem cell transplant recipients.采用不同的超声扫描方法评估造血干细胞移植受者门静脉血流和肝动脉阻力指数对肝静脉闭塞病/窦阻塞综合征的评估。
J Med Ultrason (2001). 2023 Oct;50(4):465-471. doi: 10.1007/s10396-023-01335-6. Epub 2023 Jul 4.
9
Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi - Case report and literature review.土三七致肝窦阻塞综合征的临床病理特征及诊断——病例报告并文献复习
Open Med (Wars). 2023 Jun 12;18(1):20230737. doi: 10.1515/med-2023-0737. eCollection 2023.
10
Effects of Probiotic Supernatant on Viability, Nano-Mechanical Properties of Cytoplasmic Membrane and Pro-Inflammatory Gene Expression in Human Gastric Cancer AGS Cells.益生菌上清液对人胃癌 AGS 细胞活力、细胞质膜纳米力学特性和促炎基因表达的影响。
Int J Mol Sci. 2023 Apr 27;24(9):7945. doi: 10.3390/ijms24097945.